PLC CE-marks next-generation TMR (transmyocardial revascularisation) laser:
This article was originally published in Clinica
Executive Summary
PLC Medical Systems has CE-marked for sale in Europe its next-generation CO2 laser for transmyocardial revascularisation (TMR). The new product is less than half the weight of the company's first-generation laser allowing it to be moved more easily between surgical suites, and enabling cardiac surgeons to decide intra-operatively whether to use the device to treat area of the myocardium not addressed by bypass surgery. The Franklin, Massachusetts company has already received approval to sell the device in the US, where it will be distributed by Edwards LifeSciences (see Clinica No 949, p 18).
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.